Neovasc Inc. Free Cash Flow per Share

Free Cash Flow per Share of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow per Share growth rates and interactive chart. Free cash flow per share. Calculated as operating cash flow minus capital expenditures and divided by the weighted average number of shares outstanding. Free cash flow is the cash flow available to all the investors in a company, including common stockholders, preferred shareholders, and lenders. It is usually used in discounted cash flow models to determine a company's intrinsic value.


Highlights and Quick Summary

  • Free Cash Flow per Share for the quarter ending March 31, 2022 was -2.58 (a 51.77% increase compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow per Share decreased by -0.26%
  • Annual Free Cash Flow per Share for 2021 was -10.89 (a -77.61% decrease from previous year)
  • Annual Free Cash Flow per Share for 2020 was -48.64 (a -48.72% decrease from previous year)
  • Annual Free Cash Flow per Share for 2019 was -94.86 (a -74.49% decrease from previous year)
  • Twelve month Free Cash Flow per Share ending March 31, 2022 was -9.51 (a -6.98% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow per Share decreased by -19.8% year-over-year
Trailing Free Cash Flow per Share for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-9.51 -10.22 -11.2 -11.86
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow per Share of Neovasc Inc.

Most recent Free Cash Flow per Shareof NVCN including historical data for past 10 years.

Interactive Chart of Free Cash Flow per Share of Neovasc Inc.

Neovasc Inc. Free Cash Flow per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -2.58
2021 -1.7 -2.72 -2.58 -4.47 -10.89
2020 -7.33 -11.41 -14.43 -15.82 -48.64
2019 -22.89 -22.73 -18.79 -39.25 -94.86
2018 -106.0 -74.08 -97.93 -9.11 -371.9
2017 -37706.33 -1280.28 -1252.44 -2123.87 -43770.77
2016 22559.04 -4123.26 -4176.26 -4151.59 10107.93
2015 -2466.67 -2532.52 -2247.78 -1541.28 -9010.04
2014 -1490.91 -1663.64 -690.91 -394.74 -4373.19
2013 -594.74 -826.32 -878.95 -655.56 -2921.05
2012 -226.32 -283.33 -394.44 -383.33 -1300.0
2011 -1276.47 -1276.47

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.